Solid Biosciences Inc. — Form SCHEDULE 13D/A
Filed August 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Perceptive Advisors LLC filed an amended Schedule 13D/A regarding its beneficial ownership position in Solid Biosciences Inc. (NASDAQ: SLDB), a ~$318M market-cap biotech company. The filing documents an amendment to a prior disclosure of significant shareholding; however, the specific details of the ownership stake, dollar amounts, share counts, percentage changes, and the nature of the amendment are not disclosed in the header metadata provided.
Why this rating
Amendment filing is routine SEC disclosure; specifics not in metadata. Cannot assess materiality without ownership data.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.